- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00312624
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
June 9, 2011 updated by: University of Pittsburgh
This is a pilot study to find a correlation between MRI and ICD therapy in patients with known cardiomyopathies, aiming to determine if cardiac scarring identified by MRI correlates with ventricular arrhythmias and the occurrence of ICD therapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is an observational study over a 3 year period of 50 patients with known cardiomyopathy and LVEF of 35% or less who will have ICD implantation as part of their standard of care.
All subjects will undergo a contrast-enhanced cardiac MRI using gadolinium to determine the morphological characteristics of their left ventricle prior to ICD implant.
Subjects will not be offered sedation to minimize risk, thus those suffering from claustrophobia will be excluded or dropped from participation.
MRI will be evaluated, and subjects will be followed during standard of care device interrogations for 12 months after implant.
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC Presbyterian Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with cardiomyopathy
Description
Inclusion Criteria:
- at least 18 years of age
- cardiomyopathy with LVEF 35% or less
- indication for ICD implantation
- able to provide informed consent
Exclusion Criteria:
- prior device implantation
- contraindication for MRI (i.e., metallic foreign body)
- claustrophobia
- pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Samir Saba, MD, University of Pittsburgh
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2006
Study Completion (Actual)
December 1, 2008
Study Registration Dates
First Submitted
April 6, 2006
First Submitted That Met QC Criteria
April 7, 2006
First Posted (Estimate)
April 10, 2006
Study Record Updates
Last Update Posted (Estimate)
June 10, 2011
Last Update Submitted That Met QC Criteria
June 9, 2011
Last Verified
June 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0602085
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.